Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments

Alzheimer's disease is a progressive dementia characterized in part by deposition of proteinaceous plaques in various areas of the brain. The main plaque protein component is β-amyloid, a metabolic product of the β-amyloid precursor protein. Substantial evidence has implicated β-amyloid (and ot...

Full description

Saved in:
Bibliographic Details
Published inTrends in neurosciences (Regular ed.) Vol. 20; no. 2; pp. 67 - 72
Main Authors Fraser, S.P, Suh, Y-H, Djamgoz, M.B.A
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 01.02.1997
Elsevier Science
Elsevier Sequoia S.A
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alzheimer's disease is a progressive dementia characterized in part by deposition of proteinaceous plaques in various areas of the brain. The main plaque protein component is β-amyloid, a metabolic product of the β-amyloid precursor protein. Substantial evidence has implicated β-amyloid (and other amyloidogenic fragments of the precursor protein) with the neurodegeneration observed in Alzheimer's disease. Recently, β-amyloid precursor protein and its amyloidogenic metabolic fragments have been shown to alter cellular ionic activity, either through interaction with existing channels or by de novo channel formation. Such alteration in ionic homeostasis has also been linked with cellular toxicity and might provide a molecular mechanism underlying the neurodegeneration seen in Alzheimer's disease.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ISSN:0166-2236
1878-108X
DOI:10.1016/S0166-2236(96)10079-5